新型コロナウイルスのワクチンの3回目の接種が進められるなか、“ゲームチェンジャー”になりうる成果が次々に発表された。それは錠剤を飲むタイプの新型コロナウイルス感染症の治療薬だ。複雑な温度管理が不要で流通が容易な錠剤は簡単に投与できるだけでなく、ジェネリック医薬品メーカーを通じて低所得国にも低価格で供給されることが明らかになっている。
…
Pfizer says its antiviral pill can cut 89% of COVID hospitalizations and deaths
The oral COVID-19 drug is the second to produce promising trial results.
“driven by a very generous motivation to try to find inexpensive cures”
Scientific American’s round-up and run-down of what’s up with Ivermectin. Despite what fringe physicians’ groups recommend — “twice a week for as long as [COVID] risk is elevated” — ivermectin is usually given as a one-time dose when it is used as a …
costs $56,000 per year
A few weeks ago, the FDA approved a costly Alzheimer’s drug developed by Biogen, but for what benefit?1. There is not strong evidence that Amyloid beta plaques causes Alzheimer’s disease, even if aducanumab showed a reduction in those plaques.2. Aducan…